Epigenetic Regulation of Multiple Tumor-Related Genes Leads to Suppression of Breast Tumorigenesis by Dietary Genistein

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Li, Yuanyuan ^a   Chen, Huaping ^a   Hardy, Tabitha M ^a   Tollefsbol, Trygve O ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; GENISTEIN; MYC PROTEIN; PROTEIN P16; PROTEIN P21;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BMI1 GENE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CANCER PREVENTION; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ACTIVITY; DNA PROTEIN COMPLEX; EARLY CANCER; EPIGENETIC REPRESSION; FEMALE; FOOD INTAKE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; MULTIPLE CANCER; NONHUMAN; ONCOGENE C MYC; P16 GENE; P21 GENE; PRECANCER; PROMOTER REGION; PROTEIN BINDING; SOYBEAN; THERAPY EFFECT; TUMOR GENE; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN IMMUNOPRECIPITATION; EPIGENESIS, GENETIC; FEMALE; GENISTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; REAL-TIME POLYMERASE CHAIN REACTION;

GLYCINE MAX; MUS;

EID: 84872335358     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054369     Document Type: Article

References (44)

1. Polyak K, (2007) Breast cancer: origins and evolution. J Clin Invest 117: 3155-3163.
2. Momparler RL, (2003) Cancer epigenetics. Oncogene 22: 6479-6483.
3. Bradbury AR, Olopade OI, (2007) Genetic susceptibility to breast cancer. Rev Endocr Metab Disord 8: 255-267.
4. King MC, Marks JH, Mandell JB, (2003) Group NYBCS (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302: 643-646.
5. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M, (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26: 2157-2165.
6. Nephew KP, Huang TH, (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 190: 125-133.
7. Baylin SB, Ohm JE, (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6: 107-116.
8. Kouzarides T, (2007) Chromatin modifications and their function. Cell 128: 693-705.
9. Herman JG, Baylin SB, (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054.
10. Wiklund ED, Kjems J, Clark SJ, (2010) Epigenetic architecture and miRNA: reciprocal regulators. Epigenomics 2: 823-840.
11. Gil J, Peters G, (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7: 667-677.
12. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG, (1999) In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci U S A 96: 12754-12759.
13. Meeran SM, Ahmed A, Tollefsbol TO, (2010) Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics 1: 101-116.
14. Li Y, Tollefsbol TO, (2010) Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem 17: 2141-2151.
15. Hardy TM, Tollefsbol TO, (2011) Epigenetic diet: impact on the epigenome and cancer. Epigenomics 3: 503-518.
16. Barnes S, (1995) Effect of genistein on in vitro and in vivo models of cancer. J Nutr 125: 777S-783S.
17. Henderson BE, Bernstein L, (1991) The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 18Suppl 1: S11-17.
18. Messina M, McCaskill-Stevens W, Lampe J, (2006) Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 98: 1275-1284.
19. Messina MJ, Persky V, Setchell KD, Barnes S, (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21: 113-131.
20. Shon Y, Park S, Nam K, (2006) Effective chemopreventive activity of genistein against human breast cancer cells. J Biochem Mol Biol 39: 448-451.
21. Fang M, Chen D, Sun Y, Jin Z, Christman J, et al. (2005) Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11: 7033-7041.
22. Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, et al. (2008) Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res 68: 2736-2744.
23. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A, (2001) Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 61: 6777-6782.
24. Li Y, Liu L, Andrews L, Tollefsbol T, (2009) Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int J Cancer 25: 286-296.
25. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, et al. (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464-468.
26. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, et al. (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65.
27. DeAngelis JT, Li Y, Mitchell N, Wilson L, Kim H, et al. (2011) 2D difference gel electrophoresis analysis of different time points during the course of neoplastic transformation of human mammary epithelial cells. J Proteome Res 10: 447-458.
28. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL, (2006) Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114: 567-572.
29. Fritz WA, Wang J, Eltoum IE, Lamartiniere CA, (2002) Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol 186: 89-99.
30. Mai Z, Blackburn GL, Zhou JR, (2007) Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice. Carcinogenesis 28: 1217-1223.
31. Li Y, Yuan YY, Meeran SM, Tollefsbol TO, (2010) Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. Mol Cancer 9: 274.
32. Casillas MA, Lopatina N, Andrews LG, Tollefsbol TO, (2003) Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts. Mol Cell Biochem 252: 33-43.
33. Li Y, Liu L, Tollefsbol TO, (2010) Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J 24: 1442-1453.
34. Nielsen IL, Williamson G, (2007) Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer 57: 1-10.
35. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ, (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
36. Sparmann A, van Lohuizen M, (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6: 846-856.
37. Nesbit CE, Tersak JM, Prochownik EV, (1999) MYC oncogenes and human neoplastic disease. Oncogene 18: 3004-3016.
38. Fang JY, Lu YY, (2002) Effects of histone acetylation and DNA methylation on p21(WAF1) regulation. World J Gastroenterol 8: 400-405.
39. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, et al. (1999) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13: 2678-2690.
40. Li Y, Meeran SM, Patel SN, Chen H, Hardy TM, Tollefsbol TO (2012) Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer. Molecular Cancer. Revised.
41. Shilatifard A, (2006) Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 75: 243-269.
42. Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e2888.
43. Papp B, Müller J, (2006) Histone trimethylation and the maintenance of transcriptional ON and OFF states by trxG and PcG proteins. Genes Dev 20: 2041-2054.
44. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M, (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164-168.